CAJ | 학술논문

目的：分析无皮肤切口的Medpor义管植入泪道旁路手术的有效性和安全性。方法回顾分析我院2011年3月至2012年12月收治的7例(7眼)行无皮肤切口的Medpor义管植入泪道旁路术的病例资料,观察其手术效果和并发症情况,分析手术的有效性和安全性。结果本组术后随访5~17个月。最后一次随访时溢泪症状消失或明显改善且义管冲洗通畅者5例,随访期间3例出现结膜肉芽增生物,2例出现鼻黏膜肉芽增生物,4例有不适感。结论 Medpor义管植入泪道旁路术可作为难治性泪道阻塞患者的备选治疗方法,但存在肉芽增生和不适感等不良反应。
목적：분석무피부절구적Medpor의관식입루도방로수술적유효성화안전성。방법회고분석아원2011년3월지2012년12월수치적7례(7안)행무피부절구적Medpor의관식입루도방로술적병례자료,관찰기수술효과화병발증정황,분석수술적유효성화안전성。결과본조술후수방5~17개월。최후일차수방시일루증상소실혹명현개선차의관충세통창자5례,수방기간3례출현결막육아증생물,2례출현비점막육아증생물,4례유불괄감。결론 Medpor의관식입루도방로술가작위난치성루도조새환자적비선치료방법,단존재육아증생화불괄감등불량반응。
Abstrac:Objective To analyze the efficacy and safety of medpor-coated tear drain in lacrimal bypass surgery without skin incision. Methods The data of 7 patients(7 eyes) who underwent no skin incision of lacrimal bypass surgery with medpor-coated tear drain were ret-rospective reviewed. The operation result and complications were observed. Results All patients were followed up for 5~17 months. Com-plete or significant improvement of epiphora was achieved in 5 cases at the last follow-up. Complications included conjunctival granulation hy-perplasia (3 eyes),nasal mucosal granulation hyperplasia (2 eyes),and discomfort (4 eyes). Conclusion The lacrimal bypass surgery with medpor-coated tear drain could be expected to improve epiphora of refractory lacrimal obstruction. The main complications are granulation hyperplasia and discomfort.